SG11201900127UA - Haemoglobin test kit - Google Patents

Haemoglobin test kit

Info

Publication number
SG11201900127UA
SG11201900127UA SG11201900127UA SG11201900127UA SG11201900127UA SG 11201900127U A SG11201900127U A SG 11201900127UA SG 11201900127U A SG11201900127U A SG 11201900127UA SG 11201900127U A SG11201900127U A SG 11201900127UA SG 11201900127U A SG11201900127U A SG 11201900127UA
Authority
SG
Singapore
Prior art keywords
haemoglobin
international
woodlands
singapore
pct
Prior art date
Application number
SG11201900127UA
Inventor
Lye Hock Sim
Original Assignee
Cell Id Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cell Id Pte Ltd filed Critical Cell Id Pte Ltd
Publication of SG11201900127UA publication Critical patent/SG11201900127UA/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin
    • G01N33/723—Glycosylated haemoglobin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin
    • G01N33/726—Devices
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G01N33/54387—Immunochromatographic test strips
    • G01N33/54388—Immunochromatographic test strips based on lateral flow
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)

Abstract

INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property 1111111011111111101 IIIIIIIII10111110 1 0 11H011101111111111111111 00 1111111110111111 Organization International Bureau (10) International Publication Number (43) International Publication Date .....0\"\" WO 2018/009143 Al 11 January 2018 (11.01.2018) W I PO I PCT (51) International Patent Classification: GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, G01N 33/72 (2006.01) G01N 33/558 (2006.01) UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, (21) International Application Number: TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, PCT/SG2016/050314 EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, (22) International Filing Date: TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, 07 July 2016 (07.07.2016) KM, ML, MR, NE, SN, TD, TG). (25) Filing Language: English Declarations under Rule 4.17: (26) Publication Language: English — of inventorship (Rule 4.17(iv)) (71) Applicant: CELL ID PTE LTD [SG/SG]; 31 Woodlands Published: Close, #05-30 and #05-31, Woodlands Horizon, Singapore — with international search report (Art. 21(3)) 737855 (SG). (72) Inventor: SIM, Lye Hock; c/o Cell ID Pte Ltd, 31 Wood- lands Close, #05-30 and #05-31, Woodlands Horizon, Sin- gapore 737855 (SG). (74) Agent: ONG, Lucille Frances Kheng Lu; Marks & Clerk Singapore LLP, Tanjong Pagar, P 0 Box 636, Singapore 910816 (SG). (81) Designated States (unless otherwise indicated, for every = kind of national protection available): AE, AG, AL, AM, = AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, _ CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, = = MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, — PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, —= SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. = (84) Designated States (unless otherwise indicated, for every = = kind of regional protection available): ARIPO (BW, GH, = = (54) Title: HAEMOGLOBIN TEST KIT = = 10 = 58 36 = \1I Il -4 -.: g : ,,,-.• , tp i•s, b i , .. 1 • .__.., y „..___.- , en 53, 33 1 1' 50 80 38 1-1 '11 01 99 57 0 Fig. 1 0 it . \" (57) : A haemoglobin test kit comprising: a lateral flow test strip having a sample collection portion, a conjugate portion and - a plurality of test lines downstream of the conjugate portion, the conjugate portion comprising haemoglobin antibody conjugated with ei coloured particles to bind with haemoglobin in a sample fluid; wherein each test line comprises a different concentration of haemoglobin antibody, and wherein each test line comprises a particular concentration of haemoglobin antibody tuned to bind with haemoglobin 0 in the sample fluid.
SG11201900127UA 2016-07-07 2016-07-07 Haemoglobin test kit SG11201900127UA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/SG2016/050314 WO2018009143A1 (en) 2016-07-07 2016-07-07 Haemoglobin test kit

Publications (1)

Publication Number Publication Date
SG11201900127UA true SG11201900127UA (en) 2019-02-27

Family

ID=56418584

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201900127UA SG11201900127UA (en) 2016-07-07 2016-07-07 Haemoglobin test kit

Country Status (7)

Country Link
US (1) US20190302130A1 (en)
EP (1) EP3482212A1 (en)
JP (1) JP2019526057A (en)
CN (1) CN109564228A (en)
PH (1) PH12019500048A1 (en)
SG (1) SG11201900127UA (en)
WO (1) WO2018009143A1 (en)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU602694B2 (en) * 1986-06-09 1990-10-25 Ortho Diagnostic Systems Inc. Improved colloidal gold membrane assay
JP3005303B2 (en) * 1991-01-31 2000-01-31 湧永製薬株式会社 measuring device
US5843691A (en) * 1993-05-15 1998-12-01 Lifescan, Inc. Visually-readable reagent test strip
US7067264B2 (en) * 2001-07-23 2006-06-27 Bagaria Padma S Test device for detecting human blood and method of use
ES2536112T3 (en) * 2009-05-20 2015-05-20 Relia Diagnostic Systems, Inc. Systems and methods to determine the percentage of glycohemoglobin
CN201886026U (en) * 2010-12-10 2011-06-29 四川迈克生物科技股份有限公司 Test paper tape for quick quantitative detection of glycated hemoglobin by immunochromatography
CN104345149A (en) * 2013-07-26 2015-02-11 深圳市艾瑞生物科技有限公司 Immunochromatography test strip for detecting glycosylated hemoglubin and preparation method thereof
JP5735670B1 (en) * 2014-01-14 2015-06-17 田中貴金属工業株式会社 Immunochromatographic analysis method, immunochromatographic analyzer and immunochromatographic analysis kit
US20160116489A1 (en) * 2014-10-23 2016-04-28 Biomedomics, Inc. Lateral flow immunoassay method of simultaneously detecting hemoglobin s, hemoglobin c, and hemoglobin a in newborns, infants, children, and adults
CN105527425B (en) * 2015-12-19 2017-11-14 中国科学院寒区旱区环境与工程研究所 A kind of preparation method of lily complex virus half-quantitative detection colloidal gold card

Also Published As

Publication number Publication date
US20190302130A1 (en) 2019-10-03
CN109564228A (en) 2019-04-02
EP3482212A1 (en) 2019-05-15
JP2019526057A (en) 2019-09-12
PH12019500048A1 (en) 2019-10-21
WO2018009143A1 (en) 2018-01-11

Similar Documents

Publication Publication Date Title
SG11201803703UA (en) Anti-complement factor c1q fab fragments and uses thereof
SG11201909963YA (en) Methods for treating dravet syndrome
SG11201900772YA (en) Gene editing of car-t cells for the treatment of t cell malignancies with chimeric antigen receptors
SG11201903480TA (en) Cell culture device system and methods of use thereof
SG11201408417UA (en) Smoking article for use with an internal heating element
SG11201408489PA (en) Target detection and signal amplification
SG11201407710VA (en) Compositions comprising short-acting benzodiazepines
SG11201408251SA (en) A pharmaceutical composition containing nicotinic acid and/or nicotinamide and/or tryptophan for positively influencing the intestinal microbiota
SG11201805906WA (en) Diagnostic and prognostic methods for cardiovascular diseases and events
SG11201407580YA (en) Composition comprising two antibodies engineered to have reduced and increased effector function
SG11201407910XA (en) Thermally conducting rods for use in aerosol-generating articles
SG11201805697WA (en) Multi-stage target cell enrichment using a microfluidic device
SG11201810887UA (en) Baff-r targeted chimeric antigen receptor-modified t-cells and uses thereof
SG11201809594WA (en) Nicotine particles and compositions
SG11201406787TA (en) Rnai-based therapies for cardiomyopathies, muscular dystrophies and laminopathies
SG11201808762XA (en) Diagnostic methods for patient specific therapeutic decision making in cancer care
SG11201810916WA (en) IMPROVED SYNTHESIS OF THE RADIOLABELED PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) INHIBITOR [18F]DCFPyL
SG11201408434QA (en) Targeted rna-seq methods and materials for the diagnosis of prostate cancer
SG11201407448VA (en) Low resistance microfabricated filter
SG11201807186TA (en) Medical examination gloves
SG11201903602RA (en) Use of beta-catenin as a biomarker for treating cancers using anti-dkk-1 antibody
SG11201808269YA (en) An injection and extraction ophthalmic device
SG11201408083YA (en) Compositions and methods for enhancing mobilization and proliferation of blastomere-like stem cells
SG11201807669VA (en) Edible bird's nest extract and method of extraction
SG11201907896PA (en) Optical system for monitoring the movement of people through a passageway